Linked Data API

Show Search Form

Search Results

724245
registered interest false more like this
date less than 2017-04-25more like thismore than 2017-04-25
answering body
Department for Exiting the European Union more like this
answering dept id 203 remove filter
answering dept short name Exiting the European Union more like this
answering dept sort name Exiting the European Union more like this
hansard heading Drugs: Manufacturing Industries more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Exiting the European Union, what the Government's objectives are for regulation for pharmaceuticals after the UK leaves the EU. more like this
tabling member constituency Bishop Auckland more like this
tabling member printed
Helen Goodman more like this
uin 71898 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2017-04-27more like thisremove minimum value filter
answer text <p>The Government is committed to ensuring a positive outcome for the UK life sciences and pharmaceuticals sector as we exit the European Union.</p><p>In the negotiations, the Government will discuss with the EU and Member States how best to continue to cooperate in the field of medicines regulation in the best interests of both the UK and EU. It would not be appropriate to pre-judge the outcome of the negotiations.</p><p> </p> more like this
answering member constituency Worcester more like this
answering member printed Mr Robin Walker more like this
grouped question UIN
71886 more like this
71899 more like this
question first answered
remove filter
answering member
4091
label Biography information for Mr Robin Walker more like this
tabling member
1484
label Biography information for Helen Goodman more like this